Neuphoria Therapeutics Inc. Form SUPPL: Voluntary supplemental material by a foreign issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2002-12-16: Form SUPPL; Description AUTO-GENERATED PAPER DOCUMENT; Document 9999999997-02-061405.paper.
- 2002-12-13: Form SUPPL; Description AUTO-GENERATED PAPER DOCUMENT; Document 9999999997-02-061831.paper.
- 2002-12-02: Form SUPPL; Description AUTO-GENERATED PAPER DOCUMENT; Document 9999999997-03-001364.paper.
- 2002-11-19: Form SUPPL; Description AUTO-GENERATED PAPER DOCUMENT; Document 9999999997-02-058681.paper.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2002-12-16 | SUPPL | AUTO-GENERATED PAPER DOCUMENT | 9999999997-02-061405.paper | |
| 2002-12-13 | SUPPL | AUTO-GENERATED PAPER DOCUMENT | 9999999997-02-061831.paper | |
| 2002-12-02 | SUPPL | AUTO-GENERATED PAPER DOCUMENT | 9999999997-03-001364.paper | |
| 2002-11-19 | SUPPL | AUTO-GENERATED PAPER DOCUMENT | 9999999997-02-058681.paper | |
| 2002-11-13 | SUPPL | AUTO-GENERATED PAPER DOCUMENT | 9999999997-02-060198.paper | |
| 2002-10-09 | SUPPL | AUTO-GENERATED PAPER DOCUMENT | 9999999997-02-056094.paper | |
| 2002-10-07 | SUPPL | AUTO-GENERATED PAPER DOCUMENT | 9999999997-02-056107.paper | |
| 2002-09-11 | SUPPL | AUTO-GENERATED PAPER DOCUMENT | 9999999997-02-051474.paper |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |